{"id":15576,"date":"2025-05-06T12:03:34","date_gmt":"2025-05-06T11:03:34","guid":{"rendered":"https:\/\/www.covalence.ch\/?page_id=15576"},"modified":"2025-05-06T12:04:01","modified_gmt":"2025-05-06T11:04:01","slug":"vincent-ossipow-2","status":"publish","type":"page","link":"https:\/\/www.covalence.ch\/index.php\/fr\/a-propos\/equipe\/vincent-ossipow-2\/","title":{"rendered":"Vincent Ossipow"},"content":{"rendered":"<p style=\"text-align: justify;\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-13142 alignright\" src=\"https:\/\/www.covalence.ch\/wp-content\/uploads\/2017\/06\/Vincent_Ossipow250.png\" alt=\"\" width=\"250\" height=\"247\" \/>Vincent Ossipow, Ph.D., CFA, est conseiller financier non-ex\u00e9cutif de Covalence depuis 2005. Il est associ\u00e9 de Omega Funds depuis 2014. Auparavant, Vincent a travaill\u00e9 pour Sectoral Asset Management, an investisseur institutionnel dans le domaine de la sant\u00e9, en tant qu&#8217;associ\u00e9 charg\u00e9 des investissements priv\u00e9s.<\/p>\n<p style=\"text-align: justify;\">De 2000 \u00e0 2006, Vincent a \u00e9t\u00e9 chercheur associ\u00e9 \u00e0 l&#8217;Universit\u00e9 de Gen\u00e8ve en biologie mol\u00e9culaire. Il a aussi \u00e9t\u00e9 actif au sein de la Banque Pictet comme analyste en soci\u00e9t\u00e9s de biotechnologie et co-g\u00e9rant du Pictet Biotech Fund, un v\u00e9hicule d&#8217;investissement de USD 2 milliards.<\/p>\n<p style=\"text-align: justify;\">Vincent s&#8217;est form\u00e9 comme chercheur post-doctoral (Hoffman-La-Roche and Human Frontier Science Program fellow) \u00e0 Gen\u00e8ve et au National Cancer Institute NCI \u00e0 Bethesda, Maryland (USA), et a re\u00e7u un Certificate in International Finance and Global Markets \u00e0 la Georgetown University School of Business (Washington, D.C.), un master en sciences num\u00e9riques, un master en biologie mol\u00e9culaire, et un doctorat en biologie mol\u00e9culaire de l&#8217;Universit\u00e9 de Gen\u00e8ve.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vincent Ossipow, Ph.D., CFA, est conseiller financier non-ex\u00e9cutif de Covalence depuis 2005. Il est associ\u00e9 de Omega Funds depuis 2014. Auparavant, Vincent a travaill\u00e9 pour Sectoral Asset Management, an investisseur institutionnel dans le domaine de la sant\u00e9, en tant qu&#8217;associ\u00e9 charg\u00e9 des investissements priv\u00e9s. De 2000 \u00e0 2006, Vincent a \u00e9t\u00e9 chercheur associ\u00e9 \u00e0 l&#8217;Universit\u00e9&hellip;<\/p>\n","protected":false},"author":665,"featured_media":0,"parent":14439,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"class_list":["post-15576","page","type-page","status-publish","hentry","entry","no-media"],"_links":{"self":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/pages\/15576","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/users\/665"}],"replies":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/comments?post=15576"}],"version-history":[{"count":1,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/pages\/15576\/revisions"}],"predecessor-version":[{"id":15577,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/pages\/15576\/revisions\/15577"}],"up":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/pages\/14439"}],"wp:attachment":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/media?parent=15576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}